EcoDrugPlus

Trace Amine Associated Receptor 1

Ensembl ID : ENSSLUG00000003218
Gene Symbol: TAAR1
3 Cross references
391 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSSLUG00000003181
Gene Symbol: TAAR1
3 Cross references
363 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSSLUG00000003294
Gene Symbol: TAAR1
1 Cross references
426 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSSLUG00000016677
Gene Symbol: TAAR1
1 Cross references
426 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSSLUG00000016682
Gene Symbol: TAAR1
1 Cross references
426 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSSLUG00000003286
Gene Symbol: TAAR1
3 Cross references
426 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSSLUG00000016699
Gene Symbol: TAAR1
1 Cross references
426 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSSLUG00000014666
Gene Symbol: TRPA1
3 Cross references
200 Possible Orthologues:

Transmembrane Emp24 Domain-Containing Protein 3-Like

Ensembl ID : ENSSLUG00000015568
Gene Symbol: LOC116060465
3 Cross references
186 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSSLUG00000002699
Gene Symbol: TPH1
3 Cross references
207 Possible Orthologues:

Tryptophan Hydroxylase 1b

Ensembl ID : ENSSLUG00000019041
Gene Symbol: TPH1B
1 Cross references
176 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSSLUG00000010004
Gene Symbol: TUBA4A
3 Cross references
131 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).